Cardiomyocyte and Epicardial Cell Transplant Composition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for heart failure due to myocardial injury are limited in addressing the irreversible loss of contractile myocardial tissue, as they primarily focus on symptom relief rather than tissue regeneration.
Innovation Solution
A method involving a transplant composition comprising human cardiomyocytes and in vitro-differentiated human epicardial cells, or their progeny, which are differentiated from embryonic stem cells or induced pluripotent stem cells, and include additives like ZVAD-FMK, Bcl-XL, cyclosporine A, pinacidil, and IGF-1, to enhance engraftment and regeneration of functional heart tissue.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If cardiomyocytes are transplanted alone, then the transplant procedure is simple, but engraftment efficiency is low
Solution Approach 1:
The patent combines cardiomyocytes with epicardial cells in a single transplant composition. The epicardial cells serve as a supportive microenvironment that enhances cardiomyocyte engraftment, survival, and maturation. This merging of cell types resolves the contradiction by maintaining procedural simplicity while dramatically improving engraftment efficiency through the synergistic interaction between the two cell populations.
Solution Approach 2:
The epicardial cells act as an intermediary that mediates between the transplanted cardiomyocytes and the host myocardium. They provide essential signals, structural support, and a favorable microenvironment that facilitates cardiomyocyte integration. This intermediary role enables efficient engraftment without complicating the transplant procedure.
2Device complexity
If cardiomyocytes are transplanted without supportive cells, then the composition is simple, but tissue regeneration is limited
Solution Approach 1:
The patent merges cardiomyocytes with epicardial cells to create a composite transplant composition that leverages the regenerative potential of both cell types. The epicardial cells contribute to tissue regeneration by providing growth factors, forming new vasculature, and supporting cardiomyocyte differentiation and maturation, thereby significantly enhancing overall tissue regeneration capacity.
Solution Approach 2:
The transplant composition functions as a composite biological material where cardiomyocytes and epicardial cells work synergistically. The epicardial cells provide structural and functional support that enhances the regenerative output of the cardiomyocytes, creating a composite system with properties greater than the sum of its parts.
3Adaptability or versatility
If only cardiomyocytes are used for transplantation, then the cell source is straightforward, but maturation and electrical connectivity are insufficient
Solution Approach 1:
The epicardial cells serve as an intermediary that promotes cardiomyocyte maturation and electrical connectivity. They secrete paracrine factors, form physical contacts, and create a microenvironment that drives cardiomyocyte maturation. This intermediary influence enables the transplantation of straightforward cell sources while achieving high levels of cardiomyocyte maturity and functional integration.
Solution Approach 2:
The epicardial cells perform preliminary actions to prepare the transplant site and support cardiomyocyte development. They pre-establish a favorable microenvironment, secrete maturation-promoting factors, and create conditions that enable subsequent cardiomyocyte maturation and electrical coupling before the cardiomyocytes fully integrate into the host tissue.
Data Source
AI summary
Provided herein are methods and compositions comprising cardiomyocytes and epicardial cells for the treatment of cardiac disease.